EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bromfenac versus nepafenac for pain management following transepithelial photorefractive keratectomy

Asaf Achiron, Shmuel Kagasov, Irit Barequet, Ben Klinghoffer, Tal Yahalomi, Elad Eilon, Shira Zitron, Eliya Levinger

Graefe's Archive for Clinical and Experimental Ophthalmology · 15.07.2026

DOI: 10.1007/s00417-026-07375-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Graefe's Archive for Clinical and Experimental Ophthalmology, online erschienen am 15.07.2026. Verfasst von Asaf Achiron und 7 weiteren Autor:innen. Beteiligte Einrichtung: Enaim Refractive Surgery Centers, Tel Aviv, Israel. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel Aviv University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To compare the efficacy of two topical NSAID eye drops, Bromfenac and Nepafenac, in reducing postoperative pain following transepithelial photorefractive keratectomy (t-PRK).

Methods

A total of 119 patients undergoing bilateral t-PRK were divided into three groups: Nepafenac ( n = 40), Bromfenac ( n = 40), or control ( n = 39). Nepafenac 0.1% three times daily or Bromfenac 0.07% twice daily, initiated two days preoperatively and continued for three days postoperatively. The control group received systemic paracetamol (500 mg) and ibuprofen (150 mg) tablets as needed.

Results

Overall, both Nepafenac and Bromfenac groups showed significantly lower mean pain levels compared with control group (mean difference = -2.77; 95% CI: −3.63 to − 1.91; p < 0.001, and mean difference = -2.22; 95% CI: -3.01 to -1.43; p < 0.001, respectively). Bromfenac was significantly superior to control only on days 1, 3, and 4. No statistically significant difference in mean pain levels was observed between Bromfenac and Nepafenac groups (mean difference = -0.55; 95% CI: -1.45 to 0.35; p = 0.234). While Nepafenac showed better early symptom control in pain and discomfort (stinging, tearing and light sensitivity), particularly in the first two postoperative days, Bromfenac had a better effect on ocular discomfort in the later postoperative phase on days 4 and 5. Both demonstrated comparable overall tolerability compared to the control.

Conclusion

Both Nepafenac and Bromfenac significantly reduced postoperative pain following t-PRK compared to systemic analgesia. These findings support the use of topical NSAIDs in optimizing post-PRK pain management.

Schlagwörter

Stichwörter der Autor:innen

BromfenacCorneaNepafenacPainTransepithelial photorefractive keratectomy

Autor:innen und Institutionen

  • Enaim Refractive Surgery Centers, Tel Aviv, Israel.
  • Department of Ophthalmology, Tel Aviv Sourasky Medical Center and Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Enaim Refractive Surgery Centers, Tel Aviv, Israel. shmuelkagasov@gmail.com.
  • Department of Ophthalmology, Tel Aviv Sourasky Medical Center and Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. shmuelkagasov@gmail.com.
  • Goldschleger Eye Institute, Tel Hashomer and Gray Faculty of Medical and Health Sciences, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
  • Department of Ophthalmology, Rambam Health Care Campus Affiliated with the Technion- Israel Institute of Technology, Haifa, Israel.

Förderung

  • Tel Aviv University

Zitieren

APA

Achiron, A., Kagasov, S., Barequet, I., Klinghoffer, B., Yahalomi, T., Eilon, E., Zitron, S., & Levinger, E. (2026). Bromfenac versus nepafenac for pain management following transepithelial photorefractive keratectomy. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-026-07375-1

Vancouver

Achiron A, Kagasov S, Barequet I, Klinghoffer B, Yahalomi T, Eilon E, et al. Bromfenac versus nepafenac for pain management following transepithelial photorefractive keratectomy. Graefe's Archive for Clinical and Experimental Ophthalmology. 2026. doi:10.1007/s00417-026-07375-1

BibTeX
@article{Achiron2026,
  author = {Achiron, Asaf and Kagasov, Shmuel and Barequet, Irit and Klinghoffer, Ben and Yahalomi, Tal and Eilon, Elad and Zitron, Shira and Levinger, Eliya},
  title = {Bromfenac versus nepafenac for pain management following transepithelial photorefractive keratectomy},
  journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
  year = {2026},
  doi = {10.1007/s00417-026-07375-1}
}
Kostenlos starten →